Cargando…
Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC
Tyrosine kinase inhibitors (EGFR-TKIs) targeting the epidermal growth factor receptor (EGFR) have been used in non-small cell lung carcinoma (NSCLC) for years with promising results, in particular in patients with activating mutations in the EGFR kinase domain (exon 19 E746-A750 deletion or exon 21...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522229/ https://www.ncbi.nlm.nih.gov/pubmed/28489575 http://dx.doi.org/10.18632/oncotarget.17251 |
_version_ | 1783252127791972352 |
---|---|
author | Xiao, Zunyu Song, Yan Kai, Wang Sun, Xilin Shen, Baozhong |
author_facet | Xiao, Zunyu Song, Yan Kai, Wang Sun, Xilin Shen, Baozhong |
author_sort | Xiao, Zunyu |
collection | PubMed |
description | Tyrosine kinase inhibitors (EGFR-TKIs) targeting the epidermal growth factor receptor (EGFR) have been used in non-small cell lung carcinoma (NSCLC) for years with promising results, in particular in patients with activating mutations in the EGFR kinase domain (exon 19 E746-A750 deletion or exon 21 L858R point mutation). However, despite their great success in the clinic, a significant number of patients do not respond to EGFR-TKIs, such as those carrying the L858R/T790M mutation or EGFR wild type. Thus, detecting the EGFR mutation status before EGFR-TKIs therapy is essential to ensure its efficacy. In this study, we report a novel SPECT tracer (99m)Tc-HYNIC-MPG that binds specifically to activating mutant EGFR and which could therefore be used to noninvasively select patients sensitive to EGFR-TKIs. We evaluated the capacity of (99m)Tc-HYNIC-MPG in detecting EGFR-activating mutations both in vitro and in vivo using four human NSCLC cell lines (PC9, H1975, H358 and H520). (99m)Tc-HYNIC-MPG had significantly higher accumulation in PC9 tumor cells when compared to H1975, H358 and H520 tumors cells, which may be due to the activating mutations (exon 19 deletion) in EGFR tyrosine kinase domain in PC9 cells. Thus, (99m)Tc-HYNIC-MPG SPECT imaging may be used to identify NSCLC tumors with a potential high response rate to EGFR-TKIs. |
format | Online Article Text |
id | pubmed-5522229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-55222292017-08-21 Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC Xiao, Zunyu Song, Yan Kai, Wang Sun, Xilin Shen, Baozhong Oncotarget Research Paper Tyrosine kinase inhibitors (EGFR-TKIs) targeting the epidermal growth factor receptor (EGFR) have been used in non-small cell lung carcinoma (NSCLC) for years with promising results, in particular in patients with activating mutations in the EGFR kinase domain (exon 19 E746-A750 deletion or exon 21 L858R point mutation). However, despite their great success in the clinic, a significant number of patients do not respond to EGFR-TKIs, such as those carrying the L858R/T790M mutation or EGFR wild type. Thus, detecting the EGFR mutation status before EGFR-TKIs therapy is essential to ensure its efficacy. In this study, we report a novel SPECT tracer (99m)Tc-HYNIC-MPG that binds specifically to activating mutant EGFR and which could therefore be used to noninvasively select patients sensitive to EGFR-TKIs. We evaluated the capacity of (99m)Tc-HYNIC-MPG in detecting EGFR-activating mutations both in vitro and in vivo using four human NSCLC cell lines (PC9, H1975, H358 and H520). (99m)Tc-HYNIC-MPG had significantly higher accumulation in PC9 tumor cells when compared to H1975, H358 and H520 tumors cells, which may be due to the activating mutations (exon 19 deletion) in EGFR tyrosine kinase domain in PC9 cells. Thus, (99m)Tc-HYNIC-MPG SPECT imaging may be used to identify NSCLC tumors with a potential high response rate to EGFR-TKIs. Impact Journals LLC 2017-04-19 /pmc/articles/PMC5522229/ /pubmed/28489575 http://dx.doi.org/10.18632/oncotarget.17251 Text en Copyright: © 2017 Xiao et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Xiao, Zunyu Song, Yan Kai, Wang Sun, Xilin Shen, Baozhong Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC |
title | Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC |
title_full | Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC |
title_fullStr | Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC |
title_full_unstemmed | Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC |
title_short | Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC |
title_sort | evaluation of (99m)tc-hynic-mpg as a novel spect radiotracer to detect egfr-activating mutations in nsclc |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522229/ https://www.ncbi.nlm.nih.gov/pubmed/28489575 http://dx.doi.org/10.18632/oncotarget.17251 |
work_keys_str_mv | AT xiaozunyu evaluationof99mtchynicmpgasanovelspectradiotracertodetectegfractivatingmutationsinnsclc AT songyan evaluationof99mtchynicmpgasanovelspectradiotracertodetectegfractivatingmutationsinnsclc AT kaiwang evaluationof99mtchynicmpgasanovelspectradiotracertodetectegfractivatingmutationsinnsclc AT sunxilin evaluationof99mtchynicmpgasanovelspectradiotracertodetectegfractivatingmutationsinnsclc AT shenbaozhong evaluationof99mtchynicmpgasanovelspectradiotracertodetectegfractivatingmutationsinnsclc |